* Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, 28006-Madrid, Spain; Departamento de
Bioquímica y Biología Molecular, Facultad de Medicina, Universidad Complutense de Madrid, 28040-Madrid, Spain; § National
Institute for Medical Research, Division of Cellular Immunology, Medical Research Council, London NW7 1AA, United
Kingdom;
Servicio de Inmunología, Hospital General Universitario Gregorio Marañón, 28007-Madrid, Spain
The recruitment of leukocytes from the bloodstream is a key step in the inflammatory reaction, and chemokines are among the main regulators of this process. During lymphocyte-endothelial interaction, chemokines induce the polarization of T lymphocytes, with the formation of a cytoplasmic projection (uropod) and redistribution of several adhesion molecules (ICAM-1,-3, CD43, CD44) to this structure. Although it has been reported that these cytokines regulate the adhesive state of integrins in leukocytes, their precise mechanisms of chemoattraction remain to be elucidated. We have herein studied the functional role of the lymphocyte uropod. Confocal microscopy studies clearly showed that cell uropods project away from the cell bodies of adhered lymphocytes and that polarized T cells contact other T cells through the uropod structure. Time-lapse videomicroscopy studies revealed that uropod-bearing T cells were able, through this cellular projection, to contact, capture, and transport additional bystander T cells. Quantitative analysis revealed that the induction of uropods results in a 5-10-fold increase in cell recruitment. Uropod-mediated cell recruitment seems to have physiological relevance, since it was promoted by both CD45R0+ peripheral blood memory T cells as well as by in vivo activated lymphocytes. Additional studies showed that the cell recruitment mediated by uropods was abrogated with antibodies to ICAM-1, -3, and LFA-1, whereas mAb to CD43, CD44, CD45, and L-selectin did not have a significant effect, thus indicating that the interaction of LFA-1 with ICAM-1 and -3 appears to be responsible for this process. To determine whether the increment in cell recruitment mediated by uropod may affect the transendothelial migration of T cells, we carried out chemotaxis assays through confluent monolayers of endothelial cells specialized in lymphocyte extravasation. An enhancement of T cell migration was observed under conditions of uropod formation, and this increase was prevented by incubation with either blocking anti- ICAM-3 mAbs or drugs that impair uropod formation. These data indicate that the cell interactions mediated by cell uropods represent a cooperative mechanism in lymphocyte recruitment, which may act as an amplification system in the inflammatory response.
The leukocyte adhesion to endothelium, with subsequent migration through the vascular wall towards
inflammatory foci, is a multistep process finely regulated by several proinflammatory factors (Springer, 1995 Several members of the chemokine family have recently
been identified as chemoattractants for T lymphocytes
(Schall et al., 1990 We have previously described the ability of certain Cytokines and Reagents
Recombinant human (rh) RANTES (sp. act. 2-5 × 103 U/mg, purity
>97%, endotoxin level <0.1 ng/µg cytokine) and rhMIP-1 mAbs
The anti-ICAM-3 HP2/19, TP1/24, TP1/25, 140.11, ICR2.1, anti-ICAM-1
Hu5/3, anti-CD18 Lia3/2, anti-CD11a YTH81.5, anti-CD43 TP1/36, anti-
CD44 HP2/9, anti-CD45 D3/9, anti-CD45RA RP1/11, anti-CD45RO
UCHL.1, and anti-L-selectin (CD62L) LAM1/3 mAb used have been described (Spertini et al., 1991 Protein Substrata
Recombinant chimeric ICAM-1-Fc and VCAM-1-4D-Fc, consisting of the
total extracellular domains fused to IgG1 Fc fragment, were obtained as
described (del Pozo et al., 1995). Briefly, COS-7 cells were transiently transfected with pICAM-1-Fc and pVCAM-1-4D-Fc (ICAM-1 and VCAM-1-4D
cDNAs cloned in pCD8IgG1). After 4 d, culture supernatants were precipitated with ammonium sulphate, and thereafter, chimeric proteins were
isolated by using protein A coupled to Sepharose (Pharmacia Fine Chemicals, Uppsala, Sweden). Fibronectin was purchased from Sigma Chemical
Co. BSA was purchased from Boehringer Mannheim GmbH (Mannheim,
Germany).
Cells and Cell Lines
Resting peripheral blood lymphocytes (PBL) were isolated from fresh human blood by Ficoll-Hypaque density gradient centrifugation (Pharmacia
Fine Chemicals), followed by two steps of adherence incubation on plastic
flasks (Costar Corp., Cambridge, MA) at 37°C for 1 h. CD45RA+ and
CD45R0+ T cells were prepared by exhaustive negative selection from
freshly isolated PBL using anti-CD45RO UCHL.1 or anti-CD45RA RP1/
11 mAb, respectively, and immunomagnetic beads (Dynal Inc., Oslo, Norway) as described (Vartdal et al., 1987 Immunofluorescence and Digital Confocal Microscopy
Immunofluorescence experiments were performed essentially as described (del Pozo et al., 1995). Briefly, 0.5-1 × 106 T cells (PBL, SF lymphocytes, TIL, or lymphoblasts) were incubated in flat-bottomed, 24-well
plates (Costar Corp.) in a final volume of 500 µl complete medium on coverslips coated with different protein substrata or melanoma tumor cells.
Chemokines (10 ng/ml), PMA (20 ng/ml), or 5 µg/ml HP2/19 mAb was
added, and cells were allowed to settle in a cell incubator at 37°C and 5%
CO2 atmosphere. After different periods of time, cells were fixed with
3.7% formaldehyde in PBS for 10 min at room temperature and rinsed in
TBS (50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 0.1% NaN3). To visualize
different membrane adhesion molecules, cells were stained with specific mAb. After washing, cells were incubated with a 1:50 dilution of an FITClabeled rabbit F(ab Samples for confocal microscopy were prepared as for standard immunofluorescence studies. T lymphoblasts were cytoplasmically labeled with
the fluorescent probe CFDA-SE, following manufacturer's instructions
(Molecular Probes Europe BV, Leiden, The Netherlands). Labeled T
lymphoblasts were incubated in flat-bottomed, 24-well plates (Costar
Corp.) in a final volume of 500 µl complete medium on coverslips coated
with 10 µg/ml ICAM-1-Fc or a confluent monolayer of EC. Chemokines,
control antibody (P3X63), or the anti-ICAM-3 TP1/24 or HP2/19 mAb (5 µg/ml) was added, and cells were allowed to settle in a cell incubator at
37°C and 5% CO2 for 1 h. Cells were then fixed with 3.7% formaldehyde in
PBS for 10 min at room temperature and rinsed in TBS (50 mM Tris-HCl,
pH 7.6, 150 mM NaCl, 0.1% NaN3). After washing, cells were incubated
with a 1:50 dilution of a Texas red-conjugated goat F(ab Tissue distribution of ICAM-3-bearing lymphocytes was determined
using double immunofluorescence staining. Surgical biopsy specimens
were snap frozen in liquid nitrogen. 4 µm frozen sections were cut, air
dried, and acetone fixed. Sections were overlaid with mAb supernatants
and incubated for 30 min at room temperature in a humidified chamber.
After two washings in TBS, a 1:50 dilution of Cy3-goat anti-mouse IgG
was added. After washing, the sections were saturated with 10% nonspecific mouse serum in TBS. To stain T lymphocytes, FITC-conjugated Leu
4 anti-CD3 mAb was used (Becton Dickinson, San Jose, CA). After washing, the sections were mounted in Mowiol (Calbiochem-Novabiochem, La
Jolla, CA), and confocal microscopy analysis of serial tissue sections was
carried out.
Time-Lapse Videomicroscopy
Video microscopy analysis was performed using a Nikon Diaphot 300 inverted microscope equipped with a Sony SSC-M350CE CCD black and
white videocamera coupled to a Sony SVT-5000P time lapse videocassette
recorder and a Sony PVM-1453MD video monitor. T cells (PBL, SF lymphocytes, TIL, or lymphoblasts) were incubated for 30 min at 37°C in
35-mm plastic petri dishes (Costar Corp.) previously coated with VCAM-1,
ICAM-1 (10 µg/ml), or melanoma tumor cells from a patient, in the presence of chemokines, PMA, or anti-ICAM-3 TP1/24 or HP2/19 mAb. After addition of a second cohort of T cells, cell-cell interactions were filmed
for 1 h under phase contrast using a 20× objective. Where indicated, cells of either the first or the second cohort were previously incubated for additional 15 min at 37°C with different blocking mAbs. Images were acquired
every 3.2 s, and sequential frames were photographed. In each experimental condition, the number of cells that were attached, spread, and moving
on the substrate (phase-dark cells), as well as the number of cell-cell interactions between the uropod of adhered cells and lymphocytes from the
second cohort (phase-bright cells), was counted. The recruitment index
was expressed as number of cells of the second cohort being captured per
number of cells of the first layer adhered to the substrate.
HMEC-1 Culture on Transwell Inserts and Monolayer
Integrity Testing
T lymphoblast migration through a confluent monolayer (HMEC-1) was
assayed in a Transwell cell culture chamber (Costar Corp.). The chemotaxis chambers are separated by a polycarbonate membrane (6.5 mm
diam, 10 µm thickness and 8-µm-diam pore size). Filters were coated on
their upper surface with fibronectin and layered with HMEC-1. The lower
well of the chamber was filled with HMEC-1 culture medium. The integrity of the endothelial barrier was assessed by diffusion of a trypan blue-
albumin complex across the endothelial monolayer as described
(Rotrosen and Gallin, 1986 T Lymphoblast Transendothelial Migration Assay
All assays were performed in triplicate or quadruplicate chambers, with
T cells from a single donor and HMEC-1-covered Transwell filters from
the same batch. T lymphoblasts were poured at different concentrations to
the upper compartment of the chamber in the presence of either anti-
ICAM-3 mAbs TP1/24 (IgG2a) or HP2/19 (IgG2a) at 5 µg/ml for 30 min at
37°C in a 5% CO2 atmosphere. Unbound T cells were removed, and a second cohort of 106 51Cr-labeled T lymphoblasts was added to the upper
compartment of the chamber. After different periods of time (5 min-6 h),
the percentage of cells that migrated across the endothelial cell layer was
calculated related to the total input of 51Cr-labeled T cells. In some experiments, after the induction of the uropod formation, cells of the first cohort were incubated for additional 15 min with different blocking mAbs.
Where indicated, lymphocytes were pretreated either with 10 mM butanedione monoxime or with 20 µM colchicine for 30 min at 37°C, extensively
washed, and used as described above.
Microscope Assay for Lymphoblast Transmigration
Across HEC Layers
HEC were grown to confluence in polystyrene tissue culture chamber
slides (Nunc A/S, Roskilde, Denmark). Aliquots of T lymphoblasts were
incubated with different mAb (5 µg/ml) during 15 min at 37°C, washed,
and poured onto HEC layers. After incubating for different periods of
time, unbound lymphocytes were removed by aspiration, and the HEC
layers were washed four times in prewarmed HBSS containing 1% FBS,
fixed (1% glutaraldehyde in PBS for 20 min), and stained with 1% toluidine blue. Slides were examined by two independent observers using a
Nikon Labophot-2 photomicroscope with a 60× objective. Previous studies have shown that surface-bound lymphocytes (small, round, and darkblue cells) and transmigrated cells (large, flattened, and light-blue cells)
can be easily distinguished in these slides (Ager and Mistry, 1988 Immunofluorescence Flow Cytometry Analysis
T cells were collected before and 5 h after transendothelial migration, incubated at 4°C for 30 min in PBS with the primary mAb, and washed two
times, and then FITC-conjugated goat anti-mouse F(ab Spatial Orientation of the Cellular Uropod and
ICAM-3 Distribution
To assess the spatial disposition of the cellular uropod and
the membrane distribution of ICAM-3, confocal microscopy analysis of fluorescent-labeled (green fluorescence)
T lymphoblasts, adhering to immobilized ICAM-1 was carried out in the presence of the uropod-inducing anti-
ICAM-3 HP2/19 mAb. This mAb was employed since it is
able to mimic the effect caused by chemokines on uropod
formation (Campanero et al., 1994
The Cellular Uropod Promotes Cell-Cell Contacts
in T Lymphoblasts
The projection of uropod towards outer milieu and its high
content of several adhesion molecules further suggested
its involvement in the recruitment of free lymphocytes. To
address this point we carried out a confocal microscopy
analysis of the contacts that occur between adhered, uropod-bearing lymphocytes and other T cells. Interestingly,
we found that the anchorage between those cells was located 5 µm above of the plate level and that it was mediated by the ICAM-3-bearing uropod of one cell (Fig. 2,
A-D). Three-dimensional reconstruction of all different
optical sections of the specimen and rotation of the image
clearly confirmed that the intercellular contact was mediated by the uropod (Fig. 2 E). Similar cell-cell contacts
were observed when the uropod was induced by the relevant physiological stimuli, the chemokines (Fig. 1 b).
T Cells Are Able to Recruit and Transport Other Cells
Through Their Uropods
Since confocal microscopy analysis only provided a static
view of the possible functional role of uropod, we decided
to undertake a dynamic assessment of this issue through
a time-lapse phase contrast microscopy analysis. A first
layer of T cells was allowed to attach to and spread on an
ICAM-1-coated surface, and then these cells were induced to develop uropods with the HP2/19 anti-ICAM-3 mAb or different chemokines. A second cohort of T cells
was then added, and cell-cell interactions were filmed. Attached lymphocytes in the first cohort adopted a phasedark morphology. Under conditions of uropod induction,
a significant proportion of cells of the second cohort, which
exhibited a phase-bright appearance readily distinguishable from the first cohort, were contacted, trapped, and finally engaged by cells of the first cohort (Fig. 3, A and B).
Interestingly, the adhered lymphocytes of the first cohort were moving on the ICAM-1-coated surface, displaying
the uropod in the antipodean pole relative to the advancing front of the cell, and were transporting other T cells
engaged through the uropod (Fig. 3 B). By counting the
number of cells of the second cohort that were recruited
by cells of the first layer, it was estimated that the induction of the uropod resulted in a 5-10-fold increase in cell
recruitment (Fig. 3 C). In contrast, other stimulating agents,
such as phorbol esters, that promote integrin activation but are unable to trigger uropod formation, failed to stimulate T cell recruitment (Fig. 3 C), thus underlining the
participation of uropods in this phenomenon.
Selective Recruitment of T Cells by Peripheral
Blood CD45R0+ Memory and In Vivo Activated
T Lymphocytes
Although T lymphoblasts likely represent the memoryactivated subset of T cells, the number of circulating lymphoblasts is very low. Therefore, we explored whether the
mechanism of cell recruitment mediated by uropods could
be observed in lymphocytes directly isolated from the blood.
Although these cells adhered nicely onto the ICAM-1-
coated surface, they moved less than activated T lymphoblasts, and chemokines only weakly induced lymphocyte polarization and recruitment of a second layer of unstimulated peripheral blood lymphocytes (Fig. 4 A, and data not
shown). Therefore, we decided to explore whether the
recruitment was selectively exerted by a subset of the cells.
In this regard, it has recently been reported that most of
the chemokine receptors are upregulated on the CD45R0+
memory-activated phenotype cells (Loetscher et al., 1996
We also studied lymphocyte recruitment with physiologically in vivo TIL. These lymphocytes, which infiltrate
different tumors, display an in vivo activated phenotype
(CD45R0+ CD69+) and high levels of cytotoxicity against
autologous tumor cells (Itoh et al., 1988
Involvement of ICAM-1 and ICAM-3 in Lymphocyte
Recruitment Mediated by Cell Uropods
A panel of blocking mAbs was used to dissect the adhesion
molecules involved in the lymphocyte recruitment mediated
through uropods. We found that mAb against ICAM-1 and
-3, two molecules concentrated in the uropod, efficiently
inhibited lymphocyte recruitment (Fig. 7 A). In addition,
the blockade of LFA-1, the counterreceptor for ICAM-1
and -3 (Campanero et al., 1993
Enhanced Lymphocyte Transendothelial Migration
under Conditions of Uropod Induction
To explore whether the enhancement in lymphocyte interactions mediated by uropods could result in an increase of
the transendothelial migration of the recruited cells, we carried out migration assays using a modified Boyden chamber (Transwell®; Costar Corp.) and confluent monolayers
of dermal microvascular endothelial cells (HMEC-1). We
found that the induction of uropod formation in the first
layer of T cells, adhered to EC, resulted in a significant enhancement of transmigration of 51Cr-labeled T cells of the
second cohort (Fig. 8 A); this effect was maximal at very
short time periods (45-60 min) and was detectable as early
as after 15 min (Fig. 8 B). Since lymphocyte migration was
similar at 4-6 h, irrespective of the addition of uropod-inducing mAb, it seems that the presence of uropods accelerates
transendothelial migration rather than causes an enhancement of its overall magnitude. As expected, the enhancement of transmigration was dependent on the number of
cells in the first layer of lymphocytes. Thus, 1.8 × 104 cells/
mm2 in the first layer under conditions of uropod induction, produced about a threefold enhancement in migration, compared to 4.5 × 103 lymphocytes/mm2 (Fig. 8 C).
When the role of uropod in lymphocyte migration was
studied by the migration assay described by Ager and Mistry (1988)
The role of uropod in lymphocyte migration was confirmed with blocking experiments. We found that the increase in the migration was virtually abrogated by inhibition of uropod function in the first layer of T cells by using
blocking anti-ICAM-3 mAb (Fig. 10 A). In addition, the
prevention of uropod formation with the myosin-disrupting drug butanedione monoxime also blocked the increment in transendothelial migration of the second cohort of
T cells (Fig. 10 B). This drug has previously been reported
to prevent lymphocyte polarization and redistribution of
adhesion molecules to the uropod (Campanero et al., 1994
When we analyzed the expression of the adhesion molecules that redistribute to uropods before and after migration across HMEC-1, we found that they did not show any
quantitative variation in their level of expression after
lymphocyte transmigration; moreover, migrated cells exhibited a higher polarized morphology (Table I).
Table I.
Cell Polarization and Flow Cytometric Analysis of T cells during Migration across HMEC-1
).
During this process, circulating leukocytes roll along the
endothelium interacting with immobilized cytokines that
promote the firm adhesion and subsequent arrest of leukocytes on the vessel wall. Leukocytes then migrate following a chemoattractant gradient and using integrins as
migration supporters, crossing the endothelial barrier and
the underlying extracellular matrix (ECM)1 towards the
inflammatory foci. Increasing evidence supports that chemoattractants can regulate the adhesive state of integrins in
leukocytes (Springer, 1995
), but the mechanism(s) by
which these factors guide T lymphocyte emigration remain(s) unclear.
, 1993
; Taub et al., 1993a
,b, 1995; Tanaka et al., 1993a
,b; Carr et al., 1994
; Schall and Bacon,
1994
). These cytokines are a wide family of 70-80-aa (8-10
kD) polypeptides that have been grouped into two subfamilies, the
- or "C-X-C" chemokines, including IL-8/
NAP-1, IP-10, and MGSA/gro, and the
- or "C-C"
chemokines, such as RANTES, MCP-1, -2, -3, and MIP-1
and
. Members of both subfamilies, together with lymphotactin, are able to attract different subsets of T lymphocytes (Baggiolini et al., 1994
; Schall and Bacon, 1994
). It
has been proposed that chemokines may direct T cell migration by activating lymphocyte integrins; in this regard, it has been described that several chemokines increase T
cell binding to endothelial cells (EC); (Tanaka et al.,
1993a
,b; Taub et al., 1993a
,b; Gilat et al., 1994
). Moreover,
it has been shown that MCP-1 and other C-C chemokines
regulate
1 integrin-dependent adhesion to ECM components (Carr et al., 1996
; Weber et al., 1996
). Nevertheless, it seems evident that additional mechanisms must be
involved in the emigration of lymphocytes guided by
chemokines.
and
chemokines to induce a dramatic change in T cell
shape. Chemokines induce the formation of a cytoplasmic
projection or uropod on lymphocytes adhered to either
EC, endothelial adhesion molecules, or ECM proteins,
where several key adhesion molecules are redistributed (del Pozo et al., 1995; Nieto et al., 1996
). Interestingly, the engagement of some of these molecules with specific
mAbs induced a similar effect (Campanero et al., 1994
;
Sánchez-Mateos et al., 1995
), and therefore these mAbs
can be used as powerful tools to mimic the effect caused
by chemokines on uropod formation. In this report we
demonstrate by confocal microscopy, time-lapse videomicroscopy, and migration assays that lymphocyte adhesion receptor polarization induced by chemokines can significantly contribute to lymphocyte recruitment. These findings further support that uropod-bearing leukocytes may
have a key role in inflammatory phenomena.
Materials and Methods
(sp. act. 1.6-
2.5 × 104 U/mg, purity >97%, endotoxin level <0.1 ng/µg cytokine) were purchased from R&D Systems (Minneapolis, MN). rhIL-8 (purity >98%, endotoxin level <0.1 ng/µg cytokine), rhMCP-1 (purity >99%), and rhMIP-1
(purity >99%, endotoxin level <0.1 ng/µg cytokine) were obtained from PeproTech EC Ltd. (London, UK). Butanedione monoxime, colchicine, and PMA were purchased from Sigma Chemical Co. (St. Louis, MO).
; Campanero et al., 1993
; Arroyo et al., 1994
;
del Pozo et al., 1995; Juan et al., 1994
; Landis et al., 1994
; Luscinskas et al.,
1994
; Sadhu et al., 1994
). P3X63 myeloma protein (IgG1,
) was used as
negative control.
). Paired peripheral blood and synovial fluid (SF) lymphocytes were obtained from patients with rheumatoid
arthritis (Department of Rheumatology, Hospital de la Princesa, Madrid,
Spain). Human T lymphoblasts were prepared from peripheral blood mononuclear cells by treatment with phytohemagglutinin (PHA) 0.5% (Pharmacia Fine Chemicals) for 48 h. Cells were washed and cultured in RPMI
1640 (Flow Laboratories, Irvine, Scotland) containing 10% FCS (Flow
Laboratories) and 50 U/ml IL-2 (kindly provided by Eurocetus). T lymphoblasts cultured for 7-12 d were used in all experiments. T lymphoblasts have been extensively used to study T cell adhesion and activation
(van Kooyk et al., 1991; Dransfield et al., 1992
; Campanero et al., 1993
). Melanoma cancer cells and autologous tumor infiltrating lymphocytes (TIL) were isolated from surgical specimens from patients with metastatic melanoma (Department of Pathology, Hospital Gregorio Marañón, Madrid,
Spain). Tumor cells were grown in RPMI 1640/10% FCS. TIL were cultured in AIM-V medium (GIBCO BRL, Life Technologies, Ltd., Paisley,
Scotland) containing 4% Ultroser HY (Sepracor Inc., SA, Villeneuve la
Garenne, France) and 500 U/ml IL-2. The human dermal microvascular
endothelial cell line HMEC-1 has previously been described (Ades et al.,
1992
) and was kindly provided by Drs. Ades and Lawley (Centers for Disease Control and Prevention and Emory University School of Medicine,
Atlanta, GA). HMEC-1 were grown in MCDB 131 medium (GIBCO
BRL) supplemented with 20% FCS, 10 ng/ml EGF (Promega Biotech,
Madison, WI), 1 µg/ml hydrocortisone (Sigma Chemical Co.), 20 mM
Hepes, and 10 mM L-glutamine. Primary cultures of high endothelial cells
(HEC) were established from cervical lymph nodes of F1 hybrid rats, as
previously described (Ager, 1987
). HEC were grown in RPMI 1640 containing 20% FCS, and confluent cultures were serially passaged and split
1:2. For the experiments described herein, three different HEC cell lines between passage numbers 10 and 20 were used. Previous studies have
shown that the interaction between lymphocytes and HEC is independent
of the passage number of cell cultures (Ager and Mistry, 1988
).
)2 anti-mouse IgG (Pierce, Rockford, IL) or a 1:500
dilution of a Cy3-goat anti-mouse IgG (Amersham Life Science, Pittsburgh, PA). The cells were observed using a Nikon Labophot-2 photomicroscope with 40, 60, and 100× oil immersion objectives. The proportion
of uropod-bearing cells was calculated by random choice of 10 different
fields (60× objective) of each condition and direct counting of total cells
(400-500) and uropod-bearing cells. Preparations were photographed on
either Ektachrome 400 (color pictures) or TMAX 400 (black and white)
film (Kodak Co., Rochester, NY). The latter was processed to 800-1,600
ASA with TMAX developer (Kodak Co.).
)2 anti-mouse
IgG (Caltag Laboratories, So. San Francisco, CA). Confocal microscopy analysis was performed using the confocal laser scanning system (MRC1000; Bio-Rad Laboratories Ltd., Hertfordshire, U.K.) and a Nikon Diaphot 200 inverted microscope. Images of serial cellular sections were acquired with the BioRad CoMos graphical user-interface and subsequently
processed to obtain three-dimentional reconstructions using the VoxelView (Vital Images, Inc., Fairfield, IA) software on an Indigo computer
workstation.
). Only cell monolayers with permeability
0.5% were used for the transendothelial migration assays.
). All assays were run in triplicate, and the number of lymphocytes of each type
was counted in three separate fields. The migration index was calculated
as follows: number of transmigrated cells/number of cells. Preparations
were photographed using Ektachrome 400 color film (Kodak Co.).
)2 (Caltag Laboratories) was used as secondary antibody. The fluorescence of 2,000 cells
was measured on a FACS®can (Becton Dickinson) using Lysis II software.
Results
). We found that no
ICAM-3 signal (red fluorescence) was detected in the area
of contact between cells and protein substrate (Fig. 1 a, A
and B). Interestingly, ICAM-3 fluorescence gradually increased on upper planes of uropods, displaying the highest
intensity at a distance of 7-10 µm from the plane of the coverslip, coincident with the tips of uropods (Fig. 1 a,
C-F). Similar results were obtained in experiments in
which T cells were adhered to EC instead of ICAM-1 (data
not shown). Moreover, the same morphological changes
and ICAM-3 surface redistribution effect were observed
by using chemokines. Unstimulated lymphoblasts were
also stained as controls (Fig. 1 b). Hence, these results show that uropods extend away from the large flattened
area of cell contact with the substratum, being well exposed to the outer milieu.
Fig. 1.
Cell uropods emerge away from the flattened cell bodies of adhered lymphocytes and are projected to the outer milieu. (a) Confocal fluorescence microscopy analysis of the spatial orientation of the uropod and ICAM-3 localization on T lymphoblasts adhering to ICAM-1-coated surfaces. T cells labeled with the fluorescence cytoplasmic probe CFDA-SE (green fluorescence) were allowed to bind to coverslips coated with 10 µg/ml of ICAM-1-Fc for 30 min at 37°C in the presence of the uropod inducing anti-ICAM-3 HP2/19 mAb (5 µg/ml). Cells were then fixed and stained for ICAM-3 (red fluorescence) as described in Materials and Methods. Slides were analyzed by confocal laser scanning microscopy, and optical sectioning was adjusted to the plane of adhesion (A and B), 7 (C and D), and
10 µm above (E and F). Optical sections correspond to 0.3 µm in thickness. (b) T lymphoblasts were allowed to adhere to ICAM-1 in
the presence (right column) or in the absence (left column) of 10 ng/ml RANTES, and samples were processed as in a. Cytoplasmic
(green fluorescence) and ICAM-3 membrane staining (red fluorescence) are shown. Optical sectioning was adjusted to the plane of adhesion (A), 5 (B), and 8 µm above that plane (C).
[View Larger Versions of these Images (21 + 94K GIF file)]
Fig. 2.
Lymphocyte uropods promote cell contacts between T lymphoblasts. Confocal microscopy
analysis of lymphocyte-lymphocyte interactions mediated by cell uropods. T lymphoblasts labeled with
the green fluorescent cytoplasmic probe CFDA-SE
were allowed to bind to ICAM-1-Fc-coated coverslips (10 µg/ml) for 30 min at 37°C in the presence of
the uropod inducing anti-ICAM-3 HP2/19 mAb.
Cells were then fixed and stained for ICAM-3 (red
fluorescence). Slides were analyzed as described in
Materials and Methods. Optical sections were adjusted to the plane of adhesion (A and B) or 5 µm above (C and D). E corresponds to
the three-dimensional reconstruction of cells, simultaneously showing the cytoplasmic (green) and ICAM-3 (red) staining.
[View Larger Versions of these Images (38 + 40K GIF file)]
Fig. 3.
T cells are recruited by uropod-bearing T lymphocytes. Time-lapse videomicroscopy analysis of lymphocyte-lymphocyte interactions. (A and B) The chemokine RANTES and the uropod-inducing anti-ICAM-3 HP2/19 mAb induce T cells to contact, capture,
and transport other T cells through their uropods. T lymphoblasts were allowed to bind to plastic petri dishes coated with ICAM-1-Fc
and treated with the anti-ICAM-3 uropod-inducing mAb HP2/19 (Ab, 5 µg/ml), with the isotype-matched nonuropod inducing anti-
ICAM-3 TP1/24 (Aa, 5 µg/ml), or with 10 ng/ml RANTES (B) for 30 min at 37°C. After addition of a second cohort of untreated T lymphocytes (exhibiting a phase-bright appearance readily distinguishable from the phase-dark cells of the first cohort), cell-cell interactions were filmed with a time-lapse videocassette recorder for 1 h. Time frames obtained from videotape recording of one representative
experiment are shown. White arrowheads point to uropods displayed by phase-dark cells of the first layer; black arrows indicate phasebright T lymphocytes captured by uropod-bearing cells, while the small white arrows mark the direction of movement of the adhered
cell. (Inset) Polarized lymphocyte migrating on ICAM-1-coated surface, showing the phase-dark leading edge (L) and the phase-bright
uropod (U). (C) Measurement of cell recruitment mediated by cell uropods. T lymphoblasts were allowed to bind to plastic petri dishes
coated with VCAM-1-Fc for 30 min at 37°C in the presence of medium alone, 10 ng/ml RANTES, MCP-1, MIP-1, MIP-1
, IL-8, 20 ng/
ml PMA, or 5 µg/ml anti-ICAM-3 HP2/19 and TP1/24 mAb. After addition of a second cohort of T cells, cell-cell interactions were recorded for 1 h, and the recruitment index was estimated as described in Materials and Methods. Arithmetic mean ± 1 SD of three independent experiments is shown.
[View Larger Versions of these Images (109 + 111 + 13K GIF file)]
;
Mackay, 1996
; Qin et al., 1996
). Thus, we isolated CD45RA+
naive and CD45R0+ memory peripheral blood lymphocytes and compared their ability to contact, engage, and
drive other lymphocytes. Chemokine-mediated T cell recruitment was much more efficiently promoted by CD45R0+
cells than by CD45RA+ naive cells (Fig. 4 B). Accordingly, CD45R0+ showed a higher polarized morphology,
both in basal conditions and after chemokine treatment (Fig.
4 C, b and d). CD45R0+ cells developed a proper uropod,
and they actively locomote on the ICAM-1-coated surface, whereas the CD45RA+ cells only displayed a capping
of the ICAM-3 molecule and migrated slower (Fig. 4 C
and data not shown). These data indicate that CD45R0+
memory T cells responded more efficiently to chemokines
likely due to the higher expression of chemokine receptors
on these cells and therefore can account for the T cell recruitment observed in the total population of freshly isolated lymphocytes.
Fig. 4.
Freshly isolated CD45RO+ lymphocytes are able to recruit cells through the uropod. (A and B) Measurement of cell recruitment mediated by cell uropods. The total population of PBL
(A), CD45RA+, or CD45RO+ cells (B) were allowed to bind to
plastic petri dishes coated with ICAM-1-Fc for 30 min at 37°C in
the presence of medium alone, 10 ng/ml RANTES, MCP-1, MIP1, MIP-1
, or IL-8. After addition of a second cohort of PBL
from the same donor, cell-cell interactions were recorded for 1 h,
and the recruitment index was estimated as described in Materials and Methods. Arithmetic mean ± 1 SD of four independent
experiments performed with PBL (A) or two independent ones
with CD45RA+/CD45RO+ cells (B) is shown. (C) Freshly isolated CD45RA+ (a and c) or CD45RO+ (b and d) cells were allowed to bind to coverslips coated with 10 µg/ml ICAM-1-Fc for
30 min at 37°C in the presence (c and d) or in the absence (a and
b) of 10 ng/ml MIP-1
. Fixed cells were then stained for ICAM-3
with TP1/24 mAb, and the proportion of uropod-bearing cells
was calculated as described in Materials and Methods. The percentage of polarized cells in CD45RA+ versus CD45RO+ cells
was as follows: untreated 5 vs 19%, RANTES 11 vs 29%, MCP-1 10 vs 32%, MIP-1
3 vs 26%, MIP-1
4 vs 22%, and IL-8 8 vs
20%. The cellular uropod and the cell contact area with the substratum were indeed in a distinct plane of focus.
[View Larger Versions of these Images (16 + 72K GIF file)]
). Freshly prepared
TIL adhered to autologous melanoma tumor cells displayed a polarized morphology with ICAM-3 redistribution to the cell uropod (Fig. 5 a). Moreover, TIL were found to be polarized, and ICAM-3 was found to be concentrated in the area of cell contact in the small aggregates
of T cells that infiltrate the melanoma tissue sections (Fig.
5 b). TIL were able to induce T cell recruitment when adhered to either ICAM-1- or FN80-coated surfaces (Fig.
6 a); this phenomenon was also observed when TIL adhered to a monolayer of the tumor cells that these lymphocytes infiltrated in vivo (Fig. 6 b). Additionally, we also explored the in vivo relevance of this phenomenon in the
inflammatory disease rheumatoid arthritis. Lymphocytes
isolated from either peripheral blood or synovial fluid of
these patients were polarized when adhered to ICAM-1
(20 and 77%, respectively) and consequently, were able to
recruit peripheral blood lymphocytes of the same patient
(recruitment indexes: 0.13 and 0.37, respectively).
Fig. 5.
Lymphocyte polarization occurs in vivo. (a) Lymphocyte polarization and
ICAM-3 redistribution to the
cellular uropod during TIL
binding to autologous melanoma tumor cells. TIL were
cocultured with a monolayer
of melanoma cells from the
same patient for 1 h at 37°C.
Fixed cells were then stained
for ICAM-3 with TP1/24 mAb
followed by incubation with a
Cy3-goat anti-mouse IgG, as described in Materials and
Methods. Epifluorescent and
bright field conditions were
photographed on the same
frame by double exposure. Arrows point to uropods. (b) Tissue distribution of ICAM-3 in
T lymphocytes that infiltrate a
tumor specimen. A tissue section of a lung metastatic melanoma biopsy was double immunofluorescence stained for
ICAM-3 (red fluorescence)
and CD3 (green fluorescence) as described in Materials and
Methods. Tissue sections were
analyzed by confocal laser
scanning microscopy. Serial
optical sections of 0.5 µm thick
are shown (from A to E). A
small aggregate of three lymphocytes connected through
the tissue is followed. Arrows point out the area of cell-cell
contact where ICAM-3 is concentrated.
[View Larger Versions of these Images (129 + 95K GIF file)]
Fig. 6.
TIL are able to recruit cells through the uropod. (a)
PBL or TIL were allowed to bind to plastic petri dishes coated
with 10 µg/ml ICAM-1-Fc or 20 µg/ml FN80 for 30 min at 37°C.
After addition of a second cohort of PBL, cell-cell interactions
were recorded for 1 h, and the recruitment index was estimated
as described in Materials and Methods. Arithmetic mean ± 1 SD
of three independent experiments performed with PBL and TIL
from three different donors is shown. In parallel, lymphocytes were
allowed to adhere to coverslips coated with 10 µg/ml ICAM-1-Fc
for 30 min at 37°C, fixed, and stained for ICAM-3, and the proportion of uropod-bearing cells was calculated as described in
Materials and Methods: on ICAM-1, PBL 3%, TIL 17%; on FN80,
PBL 5%, TIL 23%. (b) TIL were allowed to bind to plastic petri
dishes coated with a monolayer of melanoma cells from the same
patient for 1 h at 37°C. A second cohort of PBL was added, and
after 1 h of incubation the specimens were fixed and stained for
ICAM-3 with TP1/24 mAb as described in Materials and Methods. Same fields from two different specimens (A and B) were
photographed under bright field (left column) and epifluorescent (right column) conditions.
[View Larger Versions of these Images (142 + 11K GIF file)]
), also prevented these cell-
cell interactions. Moreover, the YTH81.5 antibody that reacts with the I domain of the LFA-1
chain subunit and
that selectively blocks the interaction with ICAM-3 but
not with ICAM-1 (Landis et al., 1994
) only produced a
partial inhibition in cell recruitment. Interestingly, antibodies to CD43 and CD44, which are also concentrated in
the uropod, as well as to CD45 that it is not redistributed (del Pozo et al., 1995) did not affect lymphocyte recruitment. Although T lymphoblasts express L-selectin (90%
positive cells; mean fluorescence intensity, 188, versus negative control 5%; mean fluorescence intensity, 15), a blocking mAb directed to L-selectin did not exert any effect on
cell recruitment as measured in the time-lapse videomicroscopy assay (Fig. 7 A). On the other hand, cell recruitment elicited by the HP2/19 anti-ICAM-3 mAb was abolished by coincubation with either of two different blocking
anti-ICAM-3 mAbs but not with an anti-CD45 mAb (Fig.
7 B). Together, these data demonstrate that the interaction of LFA-1 integrin with its ligands ICAM-1 and -3, located in the uropod, is critical for the process of lymphocyte recruitment mediated through chemokine-induced uropods.
Fig. 7.
Involvement of
ICAM-1 and -3 in lymphocyte recruitment mediated by
cell uropods. (A) T lymphoblasts adhered for 30 min at 37°C to VCAM-1-Fc coated
surfaces in the presence of 10 ng/ml RANTES were then
incubated for 15 min with the
blocking mAb anti-ICAM-3 140.11, anti-ICAM-1 Hu5/3,
anti-CD43 TP1/36, antiCD44 HP2/9, or anti-CD45
D3/9 before the addition of a
second cohort of T cells. Where indicated, the latter
cells were pretreated for 15 min with the anti-2 integrin
Lia3/2 mAb, the anti-CD11a
YTH81.5 mAb, or the anti-
L-selectin LAM1-3 mAb before addition to the first layer of T cells. The recruitment index was calculated. Arithmetic mean ± 1 SD of three independent experiments is shown. (B) Cells were allowed to adhere for 30 min at 37°C to ICAM-1-Fc
coated petri dishes in the presence of the anti-ICAM-3 uropod-inducing mAb HP2/19 and additionally incubated for 15 min at 37°C either with the blocking anti-ICAM-3 mAbs 140.11 or ICR2.1 or with the anti-CD45 D3/9 mAb before addition of the second cohort of T
cells. Arithmetic mean ± 1 SD of two independent experiments is shown.
[View Larger Version of this Image (16K GIF file)]
Fig. 8.
Effect of uropod induction on transendothelial migration of T lymphocytes. (A and B) Uropod induction increases transendothelial migration.
Migration of T lymphoblasts across confluent monolayers from a human dermal microvascular endothelial cell line (HMEC-1) was assayed in a Transwell
cell culture chamber. T lymphoblasts were allowed to bind to confluent EC
monolayers cultured on polycarbonate membranes and treated either with the
uropod-inducing mAb HP2/19 or with the noninducing anti-ICAM-3 mAb
TP1/24. A second cohort of 106 51Cr-labeled T cells was then added to the upper compartment of the chamber and incubated for long (A, from 45 min to 6 h)
and short (B, from 5 to 60 min) periods of time at 37°C in a 5% CO2 atmosphere. The percentage of cells that migrated to the lower well of the chamber
was calculated using a counter. A representative experiment out of five independent ones run in quadruplicate is shown. Error bars represent ± 1 SD of
values from quadruplicate Transwell chambers. (C) The increment in migration was dependent on the number of cells in the first layer of lymphocytes. In
similar experiments of transendothelial migration, different numbers of T lymphoblasts were incubated with the confluent EC monolayers, and migration of
a second cohort of 51Cr-labeled T cells was analyzed. Transmigration is presented as the ratio between percentage of migrated cells under uropod conditions and percentage of migrated cells under nonuropod conditions. Arithmethic mean ± 1 SD of three independent
experiments is shown.
[View Larger Versions of these Images (13 + 14 + 13K GIF file)]
, using HEC, similar results were found. In this
assay, T cells were coincubated with HEC, and after different periods of time, the number of lymphocytes bound
to the apical surface or underneath the HEC monolayer
were counted. We have also found that the induction of
the uropod caused an important increment in the migration index in short periods of time, and that this effect vanished at longer times (Fig. 9 b). Interestingly, we observed
that in these assays the interaction between migrated lymphocytes and bound T cells was also mediated through
ICAM-3-bearing uropod structures (Fig. 9, a and c), indicating that this interaction takes place during transendothelial migration.
Fig. 9.
Uropod induction increases migration across HEC.
(a) Interaction through a uropod-like structure between migrated
T cells and bound lymphocytes. D shows the usual morphology of
high endothelial vein cells. A-C show the same field photographed in a different plane of focus, from the level of HEC (A)
to the level of surface bound lymphocytes (C). E shows a different field. White arrows point to cell-cell contacts through a uropodlike structure. (b) T lymphoblasts preincubated with the indicated
mAb were added to confluent cultures of HEC in multichamber
polystyrene slides and incubated for different periods of time. After washing, adherent lymphocytes were identified as either "surface bound" or "transmigrated" by counterstaining with toluidine
blue and high power light microscopy; the migration index was
calculated as stated in Materials and Methods. A representative
experiment out of three independent ones run in triplicate is
shown. (c) In parallel, some specimens were stained for ICAM-3
after fixation as described in Materials and Methods. Same fields
were photographed under bright field (A) and epifluorescent (B)
conditions. Arrows point to ICAM-3+ uropods.
[View Larger Versions of these Images (14 + 63 + 140K GIF file)]
;
del Pozo et al., 1995).
Fig. 10.
T cell migration mediated by cell uropods is prevented
by blocking with anti-ICAM-3 mAbs or with drugs that impair
uropod formation. T cell migration across HMEC-1 was assayed
as described in Materials and Methods. (A) After treatment of the
first layer of T lymphoblasts with either HP2/19 (uropod) or TP1/
24 (control) anti-ICAM-3 mAbs, cells were incubated for additional 15 min with the indicated blocking mAbs. (B) Before the
incubation of the first layer of T cells with the EC monolayers,
lymphocytes were treated either with butanedione monoxime or
with colchicine for 30 min at 37°C, and then the drugs were extensively washed. In parallel, drug-treated lymphocytes were allowed to adhere to coverslips coated with 10 µg/ml ICAM-1-Fc
for 30 min at 37°C, fixed and stained for ICAM-3, and the proportion of uropod-bearing cells was calculated as described in
Materials and Methods: untreated control, 11%, uropod, 76%;
butanedione monoxime control, 1%, uropod 4%; colchicine control, 40%, uropod, 81%. A representative experiment out of three independent ones run in duplicate is shown.
[View Larger Versions of these Images (18 + 15K GIF file)]
Cell polarization is a complex phenomenon that results in
asymmetrical cell shape common to many cell types and
has a key role in cellular processes as diverse as activation,
differentiation, localized membrane growth, cell migration, vectorial transport of molecules across cell layers, antigen presentation, and target cell recognition and killing
(Rodriguez-Boulan and Powell, 1992; Huttenlocher et al.,
1995
; Drubin and Nelson, 1996
; Helander et al., 1996
;
Lauffenburger et al., 1996; Negulescu et al., 1996
). Lymphocytes are among the diverse cellular types that undergo polarization; activated and migrating lymphocytes
change from a spherical to a polarized cell shape, displaying a cytoplasmic projection termed uropod due to its similarity with amoeboid morphology (Haston et al., 1982
;
Wilkinson, 1986
; Wilkinson and Higgins, 1987
; Shutt et al.,
1995
). We have previously described that chemotactic and
proinflammatory chemokines are responsible for the induction of the uropod on T cells adhered to endothelial
cells, as well as for the redistribution of certain adhesion
molecules to this structure (del Pozo et al., 1995). In this
regard, it has been reported that these cytokines induce
leukocyte chemotaxis and regulate adhesive properties of
leukocyte integrins (Tanaka et al., 1993a
,b; Taub et al.,
1993a
,b; Gilat et al., 1994
; Schall and Bacon, 1994
; Carr et
al., 1996
); however, the mechanisms responsible for these
effects are poorly understood. We have found herein that
chemokine-mediated cell polarization and adhesion molecule redistribution to the cellular uropod confers T lymphocytes the ability to capture additional cells through this
structure. This phenomenon may constitute a cooperative
mechanism that can significantly contribute to the directional guidance of leukocytes to inflammatory foci induced
by chemokines.
We previously reported that uropods induced by both
chemokines and activating mAb appear to emerge away
from the flattened cell body that is adhered to EC or ECM
substrate (Campanero et al., 1994; del Pozo et al., 1995;
Sánchez-Mateos et al., 1995
;). This point was inferred from
conventional fluorescence microscopy studies in which we
moved the plane of focus through the specimen. Very interestingly, we have confirmed our early observations by using confocal laser scanning fluorescence microscopy.
This analysis allowed us to definitively conclude that the
uropod is directed to the outer milieu, being projected from
the flattened cell body, and furthermore, that this structure is able to mediate contacts among lymphocytes.
However, since confocal microscopy analysis only provided us a static approach to the understanding of the
functional role of the uropod, several key questions remained undetermined. Therefore, we decided to undertake a dynamic assessment of this issue by using a time
lapse videocassette recorder coupled to a phase contrast microscope. Interestingly, this analysis showed that attached lymphocytes are able to move over the substrate
displaying the uropod at the back of the cell, emerging
from the most distal (antipodean) pole to the leading edge
of the cell. Hence, this cellular projection corresponds exactly to the clasically defined lymphocyte uropod (Lewis,
1931; Haston et al., 1982
). It is worth mentioning that we
clearly observed that the cells captured through uropods
were tightly engaged through these cellular structures and
therefore migrated together with the uropod-bearing cell. Very importantly, we have found that this lymphocyte recruitment seems to be indeed relevant in vivo since it was
also observed when uropods were promoted by physiologic stimuli such as chemokines. This phenomenon was
strictly dependent on the presence of the uropod, since it
did not occur upon cell stimulation with other agents that
induce cell and integrin activation like phorbol esters, but
was unable to induce uropod formation. These data strongly suggest that lymphocyte-lymphocyte interactions are cooperative for cell recruitment to sites where EC have been
activated, bearing chemokines on their cell surface. On the
other hand, and although there is no precedent for capture
and transport of one leukocyte by another during transendothelial migration, there are several recent papers reporting on the synergism between leukocyte-leukocyte interactions as a novel regulatory mechanism in recruitment of leukocytes in inflammation (Bargatze et al., 1994
; Alon et al., 1996
; Jutila and Kurk, 1996
; Finger et al., 1996
; Fuhlbrigge
et al., 1996
). L-selectin plays an important role in these
cell-cell interactions as determined by blocking studies with
specific antibodies. However, in our experiments the blockade of L-selectin did not interfere with lymphocyte recruitment, since we have looked at the tight adhesion between lymphocytes (
2 integrin/ICAM-1,-3-dependent) rather than at the rolling phase observed under flow conditions (selectin-dependent; Springer, 1995
; Butcher and
Picker, 1996
). Therefore, our results do not rule out the
possible involvement of L-selectin and its carbohydrate
ligands in the process of lymphocyte recruitment under
flow conditions. In this regard, it is worth mentioning that
the ligand of P-selectin PSGL-1, which also binds L-selectin, has been detected on the uropods of activated, polarized neutrophils (Lorant el al., 1995).
Altogether our findings on cell recruitment suggested that
T cell interactions through the uropod can significantly increase migration through an endothelial barrier and underlying ECM to inflammatory foci. To further support this
point we performed specific transendothelial migration assays. Under conditions of uropod formation, lymphocyte
migration through dermal microvascular endothelial cells
was clearly enhanced. It is worth mentioning that most of
the previously reported assays of lymphocyte chemotaxis have been performed using inert polycarbonate filters. At
best, endothelial cells derived from the umbilical cord vein
(HUVEC) have been used by some authors (Roth et al.,
1995; Randolph and Furie, 1996
) in an attempt to model the
blood vessel wall. The use of HUVEC increases the signal
to background ratio of chemotaxis and provides a more
physiologic model of lymphocyte emigration from the bloodstream than the conventional in vitro chemotaxis assays
lacking endothelium (Roth et al., 1995
). However, it is evident that lymphocyte extravasation occurs primarily through postcapillary venules rather than through large vessels such
as the umbilical vein. To our knowledge, this is one of the
first reports employing microvascular endothelium specialized in diapedesis in chemotaxis assays. Furthermore,
we have also studied lymphocyte migration through high
endothelial venules. The endothelial cells from high endothelial venules stem from specialized postcapillary vascular sites in lymphoid organs that are able to support high levels of lymphocyte extravasation (Ager and Mistry, 1988
;
Girard and Springer, 1995
). Interestingly, we found that in
both systems, uropods significantly enhance T cell transmigration at very short time periods. In this regard, TNF-
stimulation of HMEC-1 also rendered an initial increment
in lymphocyte migration, whereas at longer periods of
time the transmigration level was equal to nonstimulated
EC (not shown). Therefore, different phenomena such as
the generation of lymphocyte uropods or activation of
HMEC-1 by TNF-
rendered a similar effect in transendothelial migration. It is worth mentioning the existence of
contacts through ICAM-3-bearing uropods during cell
transmigration. Unfortunately, we could not fully assess the
effect of exogenously applied chemokines on uropod formation in our migration assays, since the presence of
chemokines in the upper compartment of the chamber
would impair lymphocyte transendothelial migration towards the lower compartment by an inversion of the
chemotactic gradient generated by the dermal microvascular endothelial cells. However, our clearcut results on the effect of chemokines in T cell recruitment strongly
suggest their involvement in transendothelial migration.
Lymphocytes that are recruited into inflamed tissues
bear preferentially the memory/activated CD45R0+ phenotype (Carr et al., 1994). It is now becoming clear that within the T lineage, most of the chemokine receptors are
restricted to CD45R0+ cells (Loetscher et al., 1996
; Mackay, 1996
). T cells that migrate in response to RANTES,
MCP-1, and MIP-1
are mainly CD45RA
CD45R0+ memory T cells (Qin et al., 1996
). In this context we have found that these chemokines act preferentially on freshly isolated CD45R0+ cells inducing uropod formation, and therefore, these cells are able to recruit other T cells through
the uropod. Furthermore, physiologically in vivo activated
CD45R0+ T lymphocytes isolated from inflammatory infiltrates of rheumatoid arthritis patients and TIL displaying a highly polarized morphology were able to recruit
T cells very efficiently. Altogether, these results provide
evidence that the mechanism of uropod-mediated lymphocyte recruitment has in vivo physiologic relevance.
In additional experiments of cell recruitment, we have observed that this phenomenon is not only induced when lymphocytes are attached to adhesion molecules expressed by inflamed endothelium (VCAM-1 or ICAM-1) but also to extracellular matrix proteins such as fibronectin, as shown for TIL. In this regard, it is well known that the chemotactic gradients produced by chemokines occur underneath the endothelial barrier, and we have recently found that uropods are efficiently promoted by chemokines on lymphocytes adhered to several ECM substrates (del Pozo et al., 1995). Moreover, the adhesion molecules that redistribute to uropods do not show any quantitative variation in their level of expression after lymphocyte migration across HMEC-1, and migrated cells exhibit a higher polarized cell morphology. Therefore, it is conceivable that uropods could also play a role in leukocyte recruitment once cells have extravasated and are migrating towards the inflammatory foci. In this regard, this issue is underscored by the observations that TIL adhering to a monolayer of the original melanoma tumor cells are able to recruit other lymphocytes through the uropod. Lymphocyte recruitment mediated by uropods could therefore represent a general mechanism of major importance during a wide variety of immunological processes in which cell migration is involved.
Received for publication 30 September 1996 and in revised form 30 December 1996.
1. Abbreviations used in this paper: EC, endothelial cells; ECM, extracellular matrix; HEC, high endothelial cells; PBL, peripheral blood lymphocytes; SF, synovial fluid; TIL, tumor infiltrating lymphocytes.This work was supported by a grant SAF96-0039 from Plan Nacional de Investigación y Desarrollo, 07/44/96 from Comunidad Autónomia de Madrid, and from Asociación de la Lucha contra el Cancer to F. SánchezMadrid and by fellowships from Fondo de Investigaciones Sanitarias BAE 96/5357 (to M.A. del Pozo) and Comunidad Autónoma de Madrid (to M.C. Montoya).